The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Karang Doshi
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Karanj Doshi, a non-promoter acquirer, has acquired 2,50,000 equity shares (1.34%) of Integrated Proteins Limited through a Preferential Allotment on August 7, 2025. Before this acquisition, the acquirer held NIL shares in the company, and post-acquisition the holding stands at 1.34% (2,50,000 shares). The company's total equity share capital expanded significantly from 32,03,600 shares (Rs. 3.20 crore) to 1,87,13,600 shares (Rs. 18.71 crore), indicating a major capital infusion via the preferential issue. The acquirer is not part of the promoter/promoter group.
This is a non-promoter creeping acquisition well below the 5% SAST disclosure threshold for non-promoters, so it carries limited takeover implications. However, the large expansion of share capital via preferential allotment signals a significant capital raise, which could dilute existing shareholders and warrants attention to the use of proceeds and the identity/credibility of the allottees.